Pioglitazone + metformin (Competact)

BNF:: Endocrine
Status:: Do Not Prescribe (DNP)
Decision Date:: June 2018

Comments

Less cost-effective than separate components

Black Drug Classifications

5: Less cost-effective than current standard therapy